Effects of a gonadotropin-releasing hormone agonist on the calcium-parathyroid axis and bone turnover in women with endometriosis
article
OA: closed
CC0
⤵ 2 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This study investigated how a GnRH agonist impacts calcium and parathyroid hormone levels, along with bone turnover markers, in women diagnosed with endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (22)
- Administration of Nasal Nafarelin as Compared with Oral Danazol for Endometriosis via openalex
- A randomized double blind placebo controlled trial of the effects on bone metabolism of the combination of nafarelin acetate and norethisterone via openalex
- Clinical experience treating endometriosis with nafarelin. via openalex
- Effects of nafarelin versus danazol on lipids and calcium metabolism via openalex
- Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study via openalex
- Nafarelin for endometriosis: a large-scale, danazol-controlled trial of efficacy and safety, with 1-year follow-up via openalex
- Nafarelin for endometriosis: A large-scale, danazol-controlled trial of efficacy and safety, with 1-year follow-up via openalex
- Reduced Bone Mass in Reproductive-Aged Women with Endometriosis* via openalex
- W2091842258 via openalex
- W2119796107 via openalex
- W2124055797 via openalex
- W2129449855 via openalex
- W2151613941 via openalex
- W2167999248 via openalex
- W6678074251 via openalex
- W2029958713 via openalex
- W2031495520 via openalex
- W2037912950 via openalex
- W2038838869 via openalex
- W2051488211 via openalex
- W2060130757 via openalex
- W2077739846 via openalex
Cited by (2)
Source provenance
- europepmc
- last seen: 2026-06-13T06:22:48.782012+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:11:13.665691+00:00
License: CC0
· commercial use OK